Microglia Contributes to BAF-312 Effects on Blood-Brain Barrier Stability

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Sep 23

PMID 36139013

Authors

Simona Federica Spampinato

Giuseppe Costantino

Sara Merlo

Pier Luigi Canonico

Maria Angela Sortino

Affiliations

Soon will be listed here.

Abstract

Microglia, together with astrocytes and pericytes, cooperate to ensure blood-brain barrier (BBB) stability, modulating endothelial responses to inflammatory insults. Agonists of the sphingosine 1 phosphate (S1P) receptors, such as siponimod (BAF-312), are important pharmacological tools in multiple sclerosis and other inflammatory diseases. Modulation of S1P receptors may result in a reduced inflammatory response and increased BBB stability. An in vitro BBB model was reproduced using human-derived endothelial cells, astrocytes and microglia. Co-cultures were exposed to inflammatory cytokines (TNFα, 10 UI and IFNγ, 5 UI) in the presence of BAF-312 (100 nM), and the BBB properties and microglia role were evaluated. The drug facilitated microglial migration towards endothelial/astrocyte co-cultures, involving the activity of the metalloprotease 2 (MMP2). Microglia actively cooperated with astrocytes in the maintenance of endothelial barrier stability: in the triple co-culture, selective treatment of microglial cells with BAF-312 significantly prevented cytokines' effects on the endothelial barrier. In conclusion, BAF-312, modulating S1P receptors in microglia, may contribute to the reinforcement of the endothelial barrier at the BBB, suggesting an additional effect of the drug in the treatment of multiple sclerosis.

Citing Articles

Glioblastoma drives protease-independent extracellular matrix invasion of microglia.

Chang C, Bale A, Bhargava R, Harley B Mater Today Bio. 2025; 31:101475.

PMID: 39896278 PMC: 11787038. DOI: 10.1016/j.mtbio.2025.101475.

Signaling controversy and future therapeutical perspectives of targeting sphingolipid network in cancer immune editing and resistance to tumor necrosis factor-α immunotherapy.

Sukocheva O, Neganova M, Aleksandrova Y, Burcher J, Chugunova E, Fan R Cell Commun Signal. 2024; 22(1):251.

PMID: 38698424 PMC: 11064425. DOI: 10.1186/s12964-024-01626-6.

Release of Pro-Inflammatory/Angiogenic Factors by Retinal Microvascular Cells Is Mediated by Extracellular Vesicles Derived from M1-Activated Microglia.

Beltramo E, Mazzeo A, Porta M Int J Mol Sci. 2024; 25(1).

PMID: 38203187 PMC: 10778795. DOI: 10.3390/ijms25010015.

The role of sphingosine-1-phosphate in the development and progression of Parkinson's disease.

Wang W, Zhao Y, Zhu G Front Cell Neurosci. 2024; 17:1288437.

PMID: 38179204 PMC: 10764561. DOI: 10.3389/fncel.2023.1288437.

Microglia and the Blood-Brain Barrier: An External Player in Acute and Chronic Neuroinflammatory Conditions.

Gullotta G, Costantino G, Sortino M, Spampinato S Int J Mol Sci. 2023; 24(11).

PMID: 37298096 PMC: 10252410. DOI: 10.3390/ijms24119144.

References

Lively S, Schlichter L . Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10). Front Cell Neurosci. 2018; 12:215. PMC: 6066613. DOI: 10.3389/fncel.2018.00215. View

Lassmann H, van Horssen J, Mahad D . Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012; 8(11):647-56. DOI: 10.1038/nrneurol.2012.168. View

Spampinato S, Obermeier B, Cotleur A, Love A, Takeshita Y, Sano Y . Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?. PLoS One. 2015; 10(7):e0133392. PMC: 4511229. DOI: 10.1371/journal.pone.0133392. View

Spampinato S, Merlo S, Sano Y, Kanda T, Sortino M . Protective effect of the sphingosine-1 phosphate receptor agonist siponimod on disrupted blood brain barrier function. Biochem Pharmacol. 2021; 186:114465. DOI: 10.1016/j.bcp.2021.114465. View

McKim D, Weber M, Niraula A, Sawicki C, Liu X, Jarrett B . Microglial recruitment of IL-1β-producing monocytes to brain endothelium causes stress-induced anxiety. Mol Psychiatry. 2017; 23(6):1421-1431. PMC: 5628107. DOI: 10.1038/mp.2017.64. View

Merlo S, Sortino M . Estrogen activates matrix metalloproteinases-2 and -9 to increase beta amyloid degradation. Mol Cell Neurosci. 2012; 49(4):423-9. DOI: 10.1016/j.mcn.2012.02.005. View

Munaut C, Noel A, Hougrand O, Foidart J, Boniver J, Deprez M . Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer. 2003; 106(6):848-55. DOI: 10.1002/ijc.11313. View

Sinagra T, Merlo S, Spampinato S, De Pasquale R, Sortino M . High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes. Front Pharmacol. 2015; 6:126. PMC: 4468832. DOI: 10.3389/fphar.2015.00126. View

Subramaniam S, Federoff H . Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease. Front Aging Neurosci. 2017; 9:176. PMC: 5463358. DOI: 10.3389/fnagi.2017.00176. View

10.

Yang Y, Rosenberg G . Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011; 42(11):3323-8. PMC: 3584169. DOI: 10.1161/STROKEAHA.110.608257. View

11.

Spampinato S, Sortino M, Salomone S . Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications. Adv Pharmacol. 2022; 94:95-139. DOI: 10.1016/bs.apha.2022.02.001. View

12.

Lou N, Takano T, Pei Y, Xavier A, Goldman S, Nedergaard M . Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proc Natl Acad Sci U S A. 2016; 113(4):1074-9. PMC: 4743790. DOI: 10.1073/pnas.1520398113. View

13.

Merlo S, Caruso G, Bonfili L, Spampinato S, Costantino G, Eleuteri A . Microglial polarization differentially affects neuronal vulnerability to the β-amyloid protein: Modulation by melatonin. Biochem Pharmacol. 2022; 202:115151. DOI: 10.1016/j.bcp.2022.115151. View

14.

Akhmetzyanova E, Kletenkov K, Mukhamedshina Y, Rizvanov A . Different Approaches to Modulation of Microglia Phenotypes After Spinal Cord Injury. Front Syst Neurosci. 2019; 13:37. PMC: 6718713. DOI: 10.3389/fnsys.2019.00037. View

15.

Zenaro E, Piacentino G, Constantin G . The blood-brain barrier in Alzheimer's disease. Neurobiol Dis. 2016; 107:41-56. PMC: 5600438. DOI: 10.1016/j.nbd.2016.07.007. View

16.

Montarolo F, Martire S, Marnetto F, Valentino P, Valverde S, Capobianco M . The Selective Agonist for Sphingosine-1-Phosphate Receptors Siponimod Increases the Expression Level of Genes in Microglia Cell Line. Curr Issues Mol Biol. 2022; 44(3):1247-1256. PMC: 8947415. DOI: 10.3390/cimb44030083. View

17.

Bachiller S, Jimenez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T . Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response. Front Cell Neurosci. 2019; 12:488. PMC: 6305407. DOI: 10.3389/fncel.2018.00488. View

18.

Aldinucci D, Colombatti A . The inflammatory chemokine CCL5 and cancer progression. Mediators Inflamm. 2014; 2014:292376. PMC: 3910068. DOI: 10.1155/2014/292376. View

19.

Halder S, Milner R . A critical role for microglia in maintaining vascular integrity in the hypoxic spinal cord. Proc Natl Acad Sci U S A. 2019; 116(51):26029-26037. PMC: 6925983. DOI: 10.1073/pnas.1912178116. View

20.

Lam D, Lively S, Schlichter L . Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K channels and migration. J Neuroinflammation. 2017; 14(1):166. PMC: 5567442. DOI: 10.1186/s12974-017-0941-3. View